Webinars


The socio-economic benefits of transplantation

55.1 - The socio-economic benefits of transplantation and the burden of end-stage kidney disease in sub-Saharan Africa

Presenter: Sarah L., White, Sydney, Australia
Authors: Sarah L. White


The true scale of the burden of end-stage kidney disease in sub-Saharan Africa is unknown, but may exceed that of high-income countries on the basis of the estimated prevalence of risk factors, especially hypertension. In this presentation I will review evidence relating to the underlying burden of end-stage kidney disease in sub-Saharan Africa and then consider the need for kidney transplantation, taking into account the likely costs and benefits from a health systems perspective. Demographic, epidemiological and economic shifts will have implications for the future incidence of end-stage kidney disease in the African region, and for the level of demand for treatment; the need for kidney transplantation will therefore continue to evolve. I will propose a research agenda that would support health policy and planning relating to the provision of renal replacement therapy in the region.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi